266 related articles for article (PubMed ID: 24994553)
1. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
[TBL] [Abstract][Full Text] [Related]
2. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
[TBL] [Abstract][Full Text] [Related]
3. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
[TBL] [Abstract][Full Text] [Related]
4. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
Tan YL; Zhou DF; Zhang XY
Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
[TBL] [Abstract][Full Text] [Related]
7. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
Zhang XY; Zhang WF; Zhou DF; Chen DC; Xiu MH; Wu HR; Haile CN; Kosten TA; Kosten TR
Biol Psychiatry; 2012 Oct; 72(8):700-6. PubMed ID: 22695185
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
[TBL] [Abstract][Full Text] [Related]
11. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
[TBL] [Abstract][Full Text] [Related]
13. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
[TBL] [Abstract][Full Text] [Related]
14. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
[TBL] [Abstract][Full Text] [Related]
15. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
16. Gender difference in association of cognition with BDNF in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
[TBL] [Abstract][Full Text] [Related]
18. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
19. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.
Zhen YF; Zhang J; Liu XY; Fang H; Tian LB; Zhou DH; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2013 May; 227(1):93-100. PubMed ID: 23263460
[TBL] [Abstract][Full Text] [Related]
20. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
Park SW; Lee JG; Kong BG; Lee SJ; Lee CH; Kim JI; Kim YH
Psychiatry Clin Neurosci; 2009 Aug; 63(4):433-9. PubMed ID: 19457211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]